Global Retirement Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $189K | Buy |
+527
| New | +$161K | ﹤0.01% | 1616 |
|
|
2025
Q4 | $91.4K | Buy |
332
+100
| +43% | +$27.4K | ﹤0.01% | 1968 |
|
|
2025
Q3 | $60.9K | Buy |
232
+6
| +3% | +$1.46K | ﹤0.01% | 1790 |
|
|
2025
Q2 | $49.5K | Buy |
+226
| New | +$48.3K | ﹤0.01% | 1778 |
|
|
2024
Q4 | $146K | Sell |
446
-23
| -5% | -$7.24K | ﹤0.01% | 1088 |
|
|
2024
Q3 | $141K | Sell |
469
-365
| -44% | -$112K | ﹤0.01% | 1071 |
|
|
2024
Q2 | $275K | Buy |
834
+381
| +84% | +$135K | 0.01% | 779 |
|
|
2024
Q1 | $179K | Buy |
453
+11
| +2% | +$4.07K | 0.01% | 833 |
|
|
2023
Q4 | $153K | Sell |
442
-35
| -7% | -$12.4K | 0.01% | 862 |
|
|
2023
Q3 | $178K | Sell |
477
-95
| -17% | -$36.7K | 0.01% | 712 |
|
|
2023
Q2 | $219K | Buy |
572
+12
| +2% | +$4.29K | 0.01% | 662 |
|
|
2023
Q1 | $206K | Sell |
560
-30
| -5% | -$8.77K | 0.01% | 658 |
|
|
2022
Q4 | $139K | Buy |
590
+129
| +28% | +$30.6K | 0.01% | 706 |
|
|
2022
Q3 | $106K | Sell |
461
-32
| -6% | -$9.75K | 0.01% | 754 |
|
|
2022
Q2 | $149K | Buy |
493
+62
| +14% | +$20.2K | 0.01% | 636 |
|
|
2022
Q1 | $130K | Buy |
+431
| New | +$169K | 0.01% | 674 |
|
|
2021
Q4 | – | Sell |
-96
| Closed | -$41K | – | 1823 |
|
|
2021
Q3 | $41K | Buy |
96
+27
| +39% | +$11.4K | ﹤0.01% | 921 |
|
|
2021
Q2 | $25K | Buy |
69
+11
| +19% | +$3.63K | ﹤0.01% | 1123 |
|
|
2021
Q1 | $16K | Sell |
58
-98
| -63% | -$28K | ﹤0.01% | 1177 |
|
|
2020
Q4 | $44K | Sell |
156
-53
| -25% | -$14.9K | 0.01% | 774 |
|
|
2020
Q3 | $57K | Sell |
209
-87
| -29% | -$23K | 0.01% | 607 |
|
|
2020
Q2 | $67K | Buy |
296
+21
| +8% | +$4.13K | 0.01% | 567 |
|
|
2020
Q1 | $42K | Sell |
275
-36
| -12% | -$5.54K | 0.01% | 610 |
|
|
2019
Q4 | $47K | Buy |
311
+160
| +106% | +$23.3K | 0.01% | 663 |
|
|
2019
Q3 | $21K | Hold |
151
| – | – | ﹤0.01% | 891 |
|
|
2019
Q2 | $19K | Sell |
151
-10
| -6% | -$1.18K | ﹤0.01% | 926 |
|
|
2019
Q1 | $18K | Sell |
161
-2
| -1% | -$208 | ﹤0.01% | 866 |
|
|
2018
Q4 | $16K | Hold |
163
| – | – | ﹤0.01% | 833 |
|
|
2018
Q3 | $20K | Buy |
163
+71
| +77% | +$7.96K | ﹤0.01% | 816 |
|
|
2018
Q2 | $9K | Sell |
92
-3
| -3% | -$276 | ﹤0.01% | 1041 |
|
|
2018
Q1 | $8K | Buy |
95
+13
| +16% | +$1.22K | ﹤0.01% | 1039 |
|
|
2017
Q4 | $8K | Buy |
82
+26
| +46% | +$2.55K | ﹤0.01% | 993 |
|
|
2017
Q3 | $5K | Buy |
56
+9
| +19% | +$814 | ﹤0.01% | 1021 |
|
|
2017
Q2 | $4K | Sell |
47
-38
| -45% | -$3.5K | ﹤0.01% | 996 |
|
|
2017
Q1 | $7K | Buy |
+85
| New | +$7.11K | ﹤0.01% | 846 |
|
Other funds holding WST
GIM
Global Retirement Partners's WST Position: Q2 2026 in Review
Global Retirement Partners opened a new position in West Pharmaceutical (WST) in Q2 2026: 527 shares worth $189K. The stake represents ﹤0.01% of the portfolio and ranks #1616 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in WST as recently as Q4 2025.
Global Retirement Partners first reported a position in WST in Q1 2017 and has held it in 35 quarters since. The position peaked at $275K in Q2 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Global Retirement Partners held 527 shares of West Pharmaceutical worth $189K as of Q2 2026.
- West Pharmaceutical was a new Global Retirement Partners position in Q2 2026.
- West Pharmaceutical made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1616 holding.
- Global Retirement Partners first reported a position in West Pharmaceutical in Q1 2017 and has held it in 35 quarters since.
- Global Retirement Partners's West Pharmaceutical position peaked at $275K in Q2 2024.
- 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.